Exploring new imaging techniques for eye diseases
Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography
This study is testing a new eye imaging technique to better understand diseases like diabetic retinopathy and macular degeneration in order to improve treatment for patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 5 Years to 110 Years |
| Sex | All |
| Sponsor | Johannes Kepler University of Linz Academic / other |
| Locations | 1 site (Linz, Upper Austria) |
| Trial ID | NCT06074731 on ClinicalTrials.gov |
What this trial studies
This observational pilot study aims to investigate the morphological features of retinal diseases using a novel imaging modality known as Swept Source Optical Coherence Tomography (SS-OCT). The study will gather data on the pathomechanisms and development of conditions such as diabetic retinopathy and macular degeneration. By analyzing the acquired images, researchers hope to gain insights that could influence future disease management for affected patients.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged between 5 and 110 years who can follow instructions during the imaging procedure.
Not a fit: Patients with dementia or those unable to follow instructions during the imaging procedure may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of retinal diseases, leading to improved patient outcomes.
How similar studies have performed: While this approach is innovative, similar studies using advanced imaging techniques have shown promise in enhancing the understanding of ocular diseases.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 5 and 110 years * Ability to follow instructions during imaging procedure * Written Informed consent Exclusion Criteria: * Dementia * Inability to follow instructions during imaging procedure * Patients who do not give informed consent
Where this trial is running
Linz, Upper Austria
- Department for Ophthalmology and Optometry, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria — Linz, Upper Austria, Austria (Recruiting)
Study contacts
- Principal investigator: Matthias Bolz, Prof. Dr. — Department for Ophthalmology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria
- Study coordinator: Matthias Bolz, Prof. Dr.
- Email: matthias.bolz@kepleruniklinikum.at
- Phone: +43 (0)5 7680 83 - 1050
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.